{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T01:48:48Z","timestamp":1761702528516,"version":"build-2065373602"},"reference-count":16,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2014,6,1]],"date-time":"2014-06-01T00:00:00Z","timestamp":1401580800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2014,6,1]],"date-time":"2014-06-01T00:00:00Z","timestamp":1401580800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","nwhjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Nursing for Women's Health"],"published-print":{"date-parts":[[2014,6]]},"DOI":"10.1111\/1751-486x.12125","type":"journal-article","created":{"date-parts":[[2014,6,17]],"date-time":"2014-06-17T14:16:55Z","timestamp":1403014615000},"page":"237-241","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Treatment of Dyspareunia Secondary to Vulvovaginal Atrophy"],"prefix":"10.1016","volume":"18","author":[{"given":"Heidi Collins","family":"Fantasia","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"4","key":"10.1111\/1751-486X.12125_bb0010","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1080\/13697130902814751","article-title":"Urogenital atrophy","volume":"12","author":"Calleja\u2010Agius","year":"2009","journal-title":"Climacteric"},{"issue":"2","key":"10.1111\/1751-486X.12125_bb0015","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1111\/jsm.12377","article-title":"The efficacy and safety of ospemifene in treating dyspareunia associated with postmenopausal vulvar and vaginal atrophy: A systematic review and meta\u2010analysis","volume":"11","author":"Cui","year":"2014","journal-title":"Journal of Sexual Medicine"},{"issue":"2","key":"10.1111\/1751-486X.12125_bb0020","doi-asserted-by":"crossref","first-page":"173","DOI":"10.3109\/13697137.2013.834493","article-title":"Ospemifene 12\u2010month safety and efficacy in postmenopausal women with vulvar and vaginal atrophy","volume":"17","author":"Goldstein","year":"2014","journal-title":"Climacteric"},{"issue":"2","key":"10.1111\/1751-486X.12125_bb0025","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1002\/sm2.17","article-title":"Multidisciplinary overview of vaginal atrophy and associated genitourinary symptoms in postmenopausal women","volume":"1","author":"Goldstein","year":"2013","journal-title":"Sexual Medicine"},{"issue":"1","key":"10.1111\/1751-486X.12125_bb0030","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1001\/jama.291.1.47","article-title":"National use of postmenopausal hormone therapy: Annual trends and response to recent evidence","volume":"291","author":"Hersh","year":"2004","journal-title":"Journal of the American Medical Association"},{"issue":"3","key":"10.1111\/1751-486X.12125_bb0035","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1007\/s11136-011-9959-7","article-title":"The impact of menopause on health\u2010related quality of life: Results from the STRIDE longitudinal study","volume":"21","author":"Hess","year":"2012","journal-title":"Quality of Life Research"},{"issue":"12\u201313","key":"10.1111\/1751-486X.12125_bb0040","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1016\/j.steroids.2013.09.003","article-title":"Tissue selectivity of ospemifene: Pharmacologic profile and clinical implications","volume":"78","author":"Kangas","year":"2013","journal-title":"Steroids"},{"issue":"4","key":"10.1111\/1751-486X.12125_bb0045","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1097\/gme.0b013e3181d2ce57","article-title":"Hormone therapy discontinuation: Physician practices after the Women's Health Initiative","volume":"17","author":"Newton","year":"2010","journal-title":"Menopause: The Journal of the North American Menopause Society"},{"issue":"3","key":"10.1111\/1751-486X.12125_bb0050","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1097\/gme.0b013e31824b970a","article-title":"The 2012 hormone therapy position statement of the North American Menopause Society","volume":"19","author":"North American Menopause Society (NAMS)","year":"2012","journal-title":"Menopause: The Journal of the North American Menopause Society"},{"issue":"9","key":"10.1111\/1751-486X.12125_bb0055","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1097\/GME.0b013e3182a122c2","article-title":"Management of symptomatic vulvovaginal atrophy: 2013 position statement of The North American Menopause Society","volume":"20","author":"North American Menopause Society (NAMS)","year":"2013","journal-title":"Menopause: The Journal of the North American Menopause Society"},{"key":"10.1111\/1751-486X.12125_bb0060","article-title":"Use of SERMs for treatment in postmenopausal women","author":"Pinkerton","year":"2013","journal-title":"Journal of Steroid Biochemistry and Molecular Biology"},{"issue":"8","key":"10.1111\/1751-486X.12125_bb0065","doi-asserted-by":"crossref","first-page":"2133","DOI":"10.1111\/j.1743-6109.2009.01335.x","article-title":"Prevalence and impact of vaginal symptoms among postmenopausal women","volume":"6","author":"Santoro","year":"2009","journal-title":"Journal of Sexual Medicine"},{"year":"2013","series-title":"Prescribing information","key":"10.1111\/1751-486X.12125_bb0070"},{"issue":"4","key":"10.1111\/1751-486X.12125_bb0075","first-page":"418\u2212427","article-title":"One\u2010year long\u2010term safety extension study of ospemifene for the treatment of vulvar and vaginal atrophy in postmenopausal women with a uterus","volume":"20","author":"Simon","year":"2013","journal-title":"Menopause"},{"key":"10.1111\/1751-486X.12125_bb0080","first-page":"605","article-title":"Ospemifene for the treatment of dyspareunia associated with vulvar and vaginal atrophy: Potential benefits in bone and breast","volume":"5","author":"Soe","year":"2013","journal-title":"International Journal of Women's Health"},{"issue":"6","key":"10.1111\/1751-486X.12125_bb0085","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1111\/j.1751-486X.2012.01776.x","article-title":"An overview of chronic vaginal atrophy and options for symptom management","volume":"16","author":"Woods","year":"2012","journal-title":"Nursing for Women's Health"}],"container-title":["Nursing for Women's Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1751485115301033?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1751485115301033?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T21:40:43Z","timestamp":1761687643000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1751485115301033"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,6]]},"references-count":16,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2014,6]]}},"alternative-id":["S1751485115301033"],"URL":"https:\/\/doi.org\/10.1111\/1751-486x.12125","relation":{},"ISSN":["1751-4851"],"issn-type":[{"type":"print","value":"1751-4851"}],"subject":[],"published":{"date-parts":[[2014,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Treatment of Dyspareunia Secondary to Vulvovaginal Atrophy","name":"articletitle","label":"Article Title"},{"value":"Nursing for Women's Health","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1111\/1751-486X.12125","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 AWHONN. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}